C23H26F2O5
Neat
420.45
-20°C
Room Temperature
2326-26-3; 6alpha, 9-Difluoro-11beta, 21-dihydroxypregna-1, 4, 16-triene-3, 20-dione 21-acetate; [2-[(6S, 8S, 9R, 10S, 11S, 13S, 14S)-6, 9-difluoro-11-hydroxy-10, 13-dimethyl-3-oxo-7, 8, 11, 12, 14, 15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; 6a, 9-Difluoro-11b, 21-dihydroxy-pregna-1, 4, 16-triene-3, 20-dione; Difluprednate Impurity 16; 6alpha, 9-Difluoro-11beta, 21-dihydroxy-pregna-1, 4, 16-triene-3, 20-dione; EINECS 219-040-7; (6alpha, 11beta)-21-(Acetyloxy)-6, 9-difluoro-11-hydroxy-pregna-1, 4, 16-triene-3, 20-dione; YXASFOVLXBFEEU-LKVAYOKUSA-N; B3QNX9A6DQ; SCHEMBL2300385; DTXSID10945953; (6a, 11b)-21-(Acetyloxy)-6, 9-difluoro-11-hydroxy-Pregna-1, 4, 16-triene-3, 20-dione; FA100437; NS00048802; 6, 9-Difluoro-11-hydroxy-3, 20-dioxopregna-1, 4, 16-trien-21-yl acetate; (6alpha, 11beta)-21-(Acetyloxy)-6, 9-difluoro-11-hydroxypregna-1, 4, 16-triene-3, 20-dione; 21-(Acetyloxy)-6, 9-difluoro-11-hydroxypregna-1, 4, 16-triene-3, 20-dione, (6alpha, 11beta)-; Pregna-1, 4, 16-triene-3, 20-dione, 6alpha, 9-difluoro-11beta, 21-dihydroxy-, 21-acetate; 2-((6S, 8S, 9R, 10S, 11S, 13S, 14S)-6, 9-difluoro-11-hydroxy-10, 13-dimethyl-3-oxo-6, 7, 8, 9, 10, 11, 12, 13, 14 and 15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
[2-[(6S, 8S, 9R, 10S, 11S, 13S, 14S)-6, 9-difluoro-11-hydroxy-10, 13-dimethyl-3-oxo-7, 8, 11, 12, 14 and 15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChI=1S/C23H26F2O5/c1-12(26)30-11-19(28)15-5-4-14-16-9-18(24)17-8-13(27)6-7-22(17,3)23(16,25)20(29)10-21(14,15)2/h5-8,14,16,18,20,29H,4,9-11H2,1-3H3/t14-,16-,18-,20-,21-,22-,23-/m0/s1